Sunscreen Drug Products for Over-the-Counter Human Use; Correction

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Health and Human Services Food and Drug Administration 21 CFR Part 201 [Docket No. FDA-1978-N-0018 (formerly Docket No. FDA-1978-N-0038)] RIN 0910-AF43 AGENCY: Food and Drug Administration, HHS. ACTION: Proposed rule; correction. SUMMARY: The Food and Drug Administration (FDA) is correcting a proposed rule relating to the regulation of over-the-counter (OTC) sunscreen monograph products that appeared in the Federal Register of February 26, 2019. The document was published with formulas that were illegible. These corrections are being made to improve the accuracy of the proposed rule. DATES: Submit either electronic or written comments on the proposed rule by June 27, 2019. FOR FURTHER INFORMATION CONTACT: Kristen Hardin, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 5443, Silver Spring, MD 20993, 240-402-4246. SUPPLEMENTARY INFORMATION: In the Federal Register of February 26, 2019 ( 84 FR 6204 ), in FR Doc. 2019-03019 , on pages 6267 through 6270, the following corrections are made: 1. On page 6267, in the first column, the formula under § 201.327(i)(2)(ii)(B) is corrected to read: ( printed page 16221) 2. On page 6268, in the second column, the formula under § 201.327(i)(3)(ii)(C)( 2 ) is corrected to read: 3. On page 6268, in the second column, the formulas under § 201.327(i)(3)(ii)(D)( 2 )( i ) are corrected to read: 4. On page 6269, in the third column, the f…